Patients On Tofacitinib For RA Appear Not To Have Worsened Risk For, Severity Of Flu Infection, Research Suggests

HCPlive (11/3, Kunzmann) reports, “Adverse events due to influenza (flu) among patients with rheumatoid arthritis treated with tofacitinib (Xeljanz) do not differ significantly from rates reported among differently-treated arthritis patients or among thos...